“Superlative transactional IP work, especially in cutting-edge technologies, such as blockchain, medical technology and machine learning“ IAM MAGAZINE 2019
Yuval Horn, Ohad Mamann and Anat Polyachenko of Horn & Co. represented the shareholders of Famewave Ltd. in the acquisition of Famewave by Kitov Pharmaceuticals Ltd. (NASDAQ/TASE: KTOV) in consideration for $10 million and a simultaneous investment of $3.5 million by certain shareholders in Kitov. Famewave Ltd. was set up by the former shareholders of cCAM Biotherapeutics Ltd., which we represented in the acquisition by MSD in 2015.
